Alpha 2.0
Login Register
» Authors » Brunon Tomasiewicz

Brunon Tomasiewicz

Explore the profile of Brunon Tomasiewicz including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 26
Citations 82
Followers 0
Related Specialties
Cardiology & Vascular Diseases
General Medicine
Pharmacology
Top 10 Co-Authors
Krzysztof Reczuch
Piotr Kubler
Wojciech Wanha
Wojciech Wojakowski
Milosz Jaguszewski
Rafal Januszek
Stanislaw Bartus
Lukasz Kuzma
Mariusz Gasior
Wojciech Zimoch
Published In
Kardiol Pol
Postepy Kardiol Interwencyjnej
J Clin Med
Circ Cardiovasc Interv
J Interv Cardiol
Affiliations
Soon will be listed here.
Recent Articles
1.
Acute and short-term outcome of Intravascular Coronary Lithotripsy and Excimer Laser Coronary Atherectomy for Severe Stent Underexpansion: The Multicenter IVL-ELCA DRAGON Registry
Wanha W, Wolny R, Kleczynski P, Mattesini A, Iwanczyk S, Dziarmaga M, et al.
Kardiol Pol . 2025 Jan; 83(2):180-187. PMID: 39821623
Background: Intravascular lithotripsy (IVL) and excimer laser-coronary atherectomy (ELCA) could be both used in the percutaneous treatment of coronary stent underexpansion. Aims: To investigate the effectiveness and safety of IVL...
2.
Treatment of in-stent restenosis with ultrathin-strut versus thin-strut drug-eluting stents or drug-eluting balloons: a multicentre registry
De Filippo O, Wanha W, Sanavia T, Januszek R, Giacobbe F, Campo G, et al.
EuroIntervention . 2024 Nov; 20(21):e1340-e1354. PMID: 39492702
Background: Limited data exist on ultrathin-strut drug-eluting stent (ultrathin DES) performance in DES in-stent restenosis (ISR). Aims: We aimed to assess the efficacy and safety of ultrathin DES compared to...
3.
Drug-Eluting Balloons and Drug-Eluting Stents in Diabetic Patients Undergoing Percutaneous Coronary Intervention Due to Restenosis-DM-Dragon Registry
Niezgoda P, Kasprzak M, Kubica J, Kuzma L, Januszek R, Iwanczyk S, et al.
J Clin Med . 2024 Aug; 13(15). PMID: 39124731
: The rate of in-stent restenosis (ISR) is decreasing; however, it is still a challenge for contemporary invasive cardiologists. Therapeutic methods, including drug-eluting balloons (DEBs), intravascular lithotripsy, excimer laser coronary...
4.
Long-Term Outcomes Following Sirolimus-Coated Balloon or Drug-Eluting Stents for Treatment of In-Stent Restenosis
Wanha W, Iwanczyk S, Januszek R, Wolny R, Tomasiewicz B, Kuliczkowski W, et al.
Circ Cardiovasc Interv . 2024 Jul; 17(9):e014064. PMID: 39051094
Background: Evidence suggests that drug-coated balloons may benefit in-stent restenosis (ISR) treatment. However, the efficacy of new-generation sirolimus-coated balloon (SCB) compared with the latest generation drug-eluting stents (DESs) has not...
5.
Long-term outcomes following paclitaxel-coated balloons versus thin-strut drug-eluting stents for treatment of in-stent restenosis in chronic coronary syndrome (CCS Dragon-Registry)
Wanha W, DAscenzo F, Kuzma L, Januszek R, Iwanczyk S, Tomasiewicz B, et al.
Kardiol Pol . 2024 Jun; 82(7-8):749-759. PMID: 38887780
Background: The long-term outcomes for patients with in-stent restenosis (ISR) presenting with chronic coronary syndrome (CCS) are not well studied. Aims: We aimed to investigate the outcomes for patients with...
6.
Long-term outcomes following drug-eluting balloon or thin-strut drug-eluting stents for treatment of in-stent restenosis stratified by duration of dual antiplatelet therapy (DEB-Dragon Registry)
Januszek R, Bil J, Gilis-Malinowska N, Staszczak B, Figatowski T, Milewski M, et al.
Postepy Kardiol Interwencyjnej . 2022 Aug; 18(1):14-26. PMID: 35982740
Introduction: Data regarding the duration of dual antiplatelet therapy (DAPT) in patients with drug-eluting stent restenosis (DES-ISR) treated with percutaneous coronary intervention (PCI) and drug-eluting balloons (DEB) or DES are...
7.
Percutaneous Coronary Intervention vs. Coronary Artery Bypass Grafting for Treating In-Stent Restenosis in Unprotected-Left Main: LM-DRAGON-Registry
Wanha W, Bil J, Kolodziejczak M, Kowalowka A, Kowalewski M, Hudziak D, et al.
Front Cardiovasc Med . 2022 May; 9:849971. PMID: 35615559
Background: Data regarding management of patients with unprotected left main coronary artery in-stent restenosis (LM-ISR) are scarce. Objectives: This study investigated the safety and effectiveness of percutaneous coronary intervention (PCI)...
8.
Long-term outcomes following drug-eluting balloons vs. thin-strut drug-eluting stents for treatment of recurrent restenosis in drug-eluting stents
Wolny R, Kowalik I, Januszek R, Bil J, Figatowski T, Milewski M, et al.
Kardiol Pol . 2022 Apr; 80(7-8):765-773. PMID: 35445739
Background: There is limited data on the optimal revascularization strategy in patients with recurrent in-stent restenosis (R-ISR). Aims: To compare the long-term outcomes of patients treated with either a thin-strut...
9.
Intravascular Lithotripsy for the Treatment of Stent Underexpansion: The Multicenter IVL-DRAGON Registry
Wanha W, Tomaniak M, Wanczura P, Bil J, Januszek R, Wolny R, et al.
J Clin Med . 2022 Apr; 11(7). PMID: 35407387
Background: Whereas the efficacy and safety of intravascular lithotripsy (IVL) have been confirmed in de novo calcified coronary lesions, little is known about its utility in treating stent underexpansion. This...
10.
Clinical Outcomes following Large Vessel Coronary Artery Perforation Treated with Covered Stent Implantation: Comparison between Polytetrafluoroethylene- and Polyurethane-Covered Stents (CRACK-II Registry)
Bartus J, Januszek R, Hudziak D, Kolodziejczak M, Kuzma L, Tajstra M, et al.
J Clin Med . 2021 Nov; 10(22). PMID: 34830722
Data on the clinical outcomes comparing synthetic fluorocarbon polymer polytetrafluoroethylene- (PTFE, GraftMaster) and polyurethane- (Papyrus) covered stents (CSs) to seal coronary artery perforations (CAPs) are limited. We aimed to evaluate...